drug protocol number

CSL889_2001

drug sponsor

CSL Behring LLC

drug study

CSL889

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh), King Khalid University Hospital (Riyadh), Prince Mohammad Bin Naser Hospital (Jazan)

drug status

Ongoing

drug phase